Early identification of chronic kidney disease: it is time to enhance patient and population-based informatics tools for general practitioners

References

• Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–733.
   PubMed Web of Science ®Google Scholar
• De Nicola L, Donfrancesco C, Minutolo R, et al. Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008–12 national health examination survey. Nephrol Dial Transplant. 2015;30(5):806–814.
   PubMed Web of Science ®Google Scholar
• Pesce F, Pasculli D, Pasculli G, et al. “The disease awareness innovation network” for chronic kidney disease identification in general practice. J Nephrol. 2022;35(8):2057–2065.
   PubMed Web of Science ®Google Scholar
• Kelly DM, Anders HJ, Bello AK, et al. International society of nephrology global kidney health atlas: structures, organization, and services for the management of kidney failure in Western Europe. Kidney Int Suppl. 2021;11(2):e106–e118.
   Web of Science ®Google Scholar
• Minutolo R, Lapi F, Chiodini P, et al. Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study. Clin J Am Soc Nephrol. 2014;9(9):1586–1593.
   PubMed Web of Science ®Google Scholar
• Minutolo R, De Nicola L, Mazzaglia G, et al. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study From Italy. Am J Kidney Dis. 2008;52(3):444–453.
   PubMed Web of Science ®Google Scholar
• Tangri N, De Nicola L. Findings and implications of the REVEAL-CKD study investigating the global prevalence of undiagnosed stage G3 chronic kidney disease. EMJ. 2022;2022:60–65.
   Google Scholar
• John Sperati C, Soman S, Agrawal V, et al. Primary care physicians’ perceptions of barriers and facilitators to management of chronic kidney disease: a mixed methods study. PLoS One. 2019;14(8):e0221325.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108(17):2154–2169.
   PubMed Web of Science ®Google Scholar
• Levin A, Stevens PE, Bilous RW, Coresh J, de Francisco ALM, de Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Vol. 3. Kidney International Supplements; 2013.
   Google Scholar
• Stanaway JD, Afshin A, Gakidou E, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1923–1994.
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Tummalapalli SL, Boulware LE, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2021;99(1):34–47.
   PubMed Web of Science ®Google Scholar
• Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–735.
   PubMed Web of Science ®Google Scholar
• Carroll JK, Pulver G, Dickinson LM, et al. Effect of 2 clinical decision support strategies on chronic kidney disease outcomes in primary care: a cluster randomized trial. JAMA Netw Open. 2018;1(6):e183377.
   PubMed Web of Science ®Google Scholar
• Joshi P, Navaneethan SD, Estrella MM. Moving beyond tools and building bridges: lessons learned From a CKD decision support in primary care. Kidney Med. 2022;4(7):35789757.
   Google Scholar
• Samal L, D’Amore JD, Gannon MP, et al. Impact of kidney failure risk prediction clinical decision support on monitoring and referral in primary care management of CKD: a randomized pragmatic clinical trial. Kidney Med. 2022;4(7):35866010.
   Google Scholar
• Rossom RC, Crain AL, O’Connor PJ, et al. Effect of clinical decision support on cardiovascular risk among adults With bipolar disorder, schizoaffective disorder, or schizophrenia: a cluster randomized clinical trial. JAMA Netw Open. 2022;5(3):E220202.
   PubMed Web of Science ®Google Scholar
• Gold R, Larson AE, Sperl-Hillen JM, et al. Effect of clinical decision support at community health centers on the risk of cardiovascular disease: a cluster randomized clinical trial. JAMA Netw Open. 2022;5(2):e2146519.
   PubMed Web of Science ®Google Scholar
• Shi X, He J, Lin M, et al. Comparative effectiveness of team-based care with and without a clinical decision support system for diabetes management nagecluster randomized trial. Ann Intern Med. 2023;176(1):49–58.
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Nordin JD, Sinaiko AR, et al. TeenBP: development and piloting of an EHR-linked clinical decision support system to improve recognition of hypertension in adolescents. eGEMs. 2015;3(2):9.
   Google Scholar
• Nelson RG, Grams ME, Ballew SH, et al. Development of risk prediction equations for incident chronic kidney disease. JAMA. 2019;322(21):2104–2114.
   PubMed Web of Science ®Google Scholar
• Ilyas H, Ali S, Ponum M, et al. Chronic kidney disease diagnosis using decision tree algorithms. BMC Nephrol. 2021;22(1):273.
   PubMed Web of Science ®Google Scholar
• Andaur Navarro CL, Damen JAA, Takada T, et al. Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review. The BMJ. 2021;2021:375.
   Google Scholar
• Higdon R. Generalized additive models. In: Encyclopedia of systems biology. New York (NY): Springer New York; 2013. p. 814–815.
   Google Scholar
• Cricelli I, Marconi E, Lapi F. Clinical decision support system (CDSS) in primary care: from pragmatic use to the best approach to assess their benefit/risk profile in clinical practice. Curr Med Res Opin. 2022;38(5):827–829.
   PubMed Web of Science ®Google Scholar
• Cricelli I, Lapi F, Montalbano C, et al. Mille general practice governance (MilleGPG): an interactive tool to address an effective quality of care through the Italian general practice network. Prim Health Care Res Dev. 2013;14(4):409–412.
   PubMed Web of Science ®Google Scholar
• Manns B, Hemmelgarn B, Tonelli M, et al. Population based screening for chronic kidney disease: cost effectiveness study. BMJ. 2010;341(7781):1036.
   Google Scholar
• Boulware LE, Jaar BG, Tarver-Carr ME, et al. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA. 2003;290(23):3101–3114.
   PubMed Web of Science ®Google Scholar
• Fink HA, Ishani A, Taylor BC, et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the US preventive services task force and for an American college of physicians clinical practice guideline. Ann Intern Med. 2012;156(8):570–581.
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)z. Kidney Int. 2005;67(6):2089–2100.
   PubMed Web of Science ®Google Scholar
• Tonelli M, Dickinson JA. Early detection of CKD: implications for low-income, middle-income, and high-income countries. J Am Soc Nephrol. 2020;31(9):1931–1940.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension. 2003;42(5):1050–1065.
   PubMed Web of Science ®Google Scholar
• Heerspink HJL, Kosiborod M, Inzucchi SE, et al. Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. Kidney Int. 2018;94(1):26–39.
   PubMed Web of Science ®Google Scholar
• Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436–1446.
   PubMed Web of Science ®Google Scholar
• Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380(24):2295–2306.
   PubMed Web of Science ®Google Scholar
• Minutolo R, Liberti ME, Provenzano M, et al. Generalizability of DAPA-CKD trial to the real-world setting of outpatient CKD clinics in Italy. Nephrol Dial Transplant. 2022;37(12):2591–2593.
   PubMed Web of Science ®Google Scholar